Trademark: 88822999
Word
TLOGEX
Status
Dead
Status Code
606
Status Date
Monday, April 3, 2023
Serial Number
88822999
Mark Type
4000
Filing Date
Thursday, March 5, 2020
Published for Opposition
Tuesday, June 30, 2020
Abandoned Date
Monday, April 3, 2023

Trademark Owner History
Amgen Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith

Trademark Events
Apr 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 3, 2023
Abandonment - No Use Statement Filed
Jun 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 3, 2022
Sou Extension 4 Granted
Jun 3, 2022
Sou Extension 4 Filed
Jun 3, 2022
Teas Extension Received
Apr 29, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 29, 2022
Teas Change Of Correspondence Received
Apr 29, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 29, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 29, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2022
Teas Change Of Owner Address Received
Jan 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2022
Sou Extension 3 Granted
Jan 24, 2022
Sou Extension 3 Filed
Jan 24, 2022
Teas Extension Received
Aug 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2021
Sou Extension 2 Granted
Aug 5, 2021
Sou Extension 2 Filed
Aug 5, 2021
Teas Extension Received
Feb 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2021
Sou Extension 1 Granted
Feb 16, 2021
Sou Extension 1 Filed
Feb 16, 2021
Teas Extension Received
Aug 25, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 30, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 30, 2020
Published For Opposition
Jun 10, 2020
Notification Of Notice Of Publication E-Mailed
May 28, 2020
Approved For Pub - Principal Register
May 25, 2020
Assigned To Examiner
Mar 11, 2020
New Application Office Supplied Data Entered
Mar 9, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24